clinmedКлиническая медицинаClinical Medicine (Russian Journal)0023-21492412-1339ООО «Медицинское информационное агентство»10.30629/0023-2149-2020-98-7-536-542clinmed-101Research ArticleВ ПОМОЩЬ ПРАКТИЧЕСКОМУ ВРАЧУGUIDELINES FOR PRACTITIONERSПериодическая болезнь (семейная средиземноморская лихорадка) у жителей ДагестанаCases of Periodic Disease (Familial Mediterranean fever) among Dagestan Republic populationЭседовЭ. М.EsedovE. M.

367000, Махачкала

Makhachkala, 367000

АбасоваА. С.AbasovaA. S.

Абасова Альбина Серажудинова — кандидат медицинских наук, доцент кафедры госпитальной терапии

367000, Махачкала

 

Albina S. Abasova — MD. PhD, Assotiate Professor of the Department of Hospital Therapy № 2

Makhachkala, 367000

albinadgma@mail.ruМеджидоваР. А.MedzhidovaR. A.

367000, Махачкала

Makhachkala, 367000

БиячуеваЛ. А.BiyachuevaL. A.

367000, Махачкала

Makhachkala, 367000

ФГБОУ «Дагестанский государственный медицинский университет» Минздрава РоссииРоссияDagestan State Medical UniversityRussian Federation202031122020967536542Copyright © Эседов Э.М., Абасова А.С., Меджидова Р.А., Биячуева Л.А., 20202020Эседов Э.М., Абасова А.С., Меджидова Р.А., Биячуева Л.А.Esedov E.M., Abasova A.S., Medzhidova R.A., Biyachueva L.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinmedjournal.com/jour/article/view/101

В статье представлен краткий обзор современных представлений о периодической болезни (семейной средиземноморской лихорадке). Приведены рекомендации по диагностике и своевременному лечению колхицином как протекции развития амилоидоза почек на основе анализа собственного клинического материала.

The article represents a brief overwiev of current understanding concerning Periodic Disease (Familial Mediterranean fever). There are some recommendations for diagnostics and modern treatment with the use of Colchicine, as a protection from kidney amyloidosis development. Materials are based on the analysis of our own clinical data.

периодическая болезньсемейная средиземноморская лихорадкапиринколхицинмутация гена МЕFV (Mеditerranian FeVer)Periodic DiseaseFamilial Mediterranean feverpyrinecolchicinemutation of MEFV geneReferencesBen-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat. Rev. Rheumatol. 2011;7(2):105– 112.Ben-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat. Rev. Rheumatol. 2011;7(2):105– 112.Onen F. Familial Mediterranean fever. Rheumatol. Int. 2006;26(6):489–946.Onen F. Familial Mediterranean fever. Rheumatol. Int. 2006;26(6):489–946.Janeway T.C., Mosenthal H. Unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of nitrogen metabolism. Trans. Assoc. Am. Physicians. 1908;23:504–518.Janeway T.C., Mosenthal H. Unusual paroxysmal syndrome, probably allied to recurrent vomiting, with a study of nitrogen metabolism. Trans. Assoc. Am. Physicians. 1908;23:504–518.Siegal S. Benign paroxysmal peritonitis. Ann. Intern. Med. 1945;13:1–22.Siegal S. Benign paroxysmal peritonitis. Ann. Intern. Med. 1945;13:1–22.Mamou H., Cattan R. La maladie periodique. Sem. Hop. Paris 1952;28:1062–1070.Mamou H., Cattan R. La maladie periodique. Sem. Hop. Paris 1952;28:1062–1070.Heller H., Sohar E., Sherf L. Familial Mediterranean fever. AMA Arch. Intern. Med. 1958;102(1):50–71.Heller H., Sohar E., Sherf L. Familial Mediterranean fever. AMA Arch. Intern. Med. 1958;102(1):50–71.Goldfinger S.E. Colchicine for familial Mediterranean fever. N. Engl. J. Med. 1972;287(25):1302.Goldfinger S.E. Colchicine for familial Mediterranean fever. N. Engl. J. Med. 1972;287(25):1302.The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807.The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90(4):797–807.French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 1997;17(1):25–31.French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 1997;17(1):25–31.Fonnesu C., Cerquaglia C., Giovinale M. et al. Familial Medi terra nean Fever: a review for clinical management. Joint Bone Spine 2009;76(3):227–233.Fonnesu C., Cerquaglia C., Giovinale M. et al. Familial Medi terra nean Fever: a review for clinical management. Joint Bone Spine 2009;76(3):227–233.Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin. Exp. Rheumatol. 2004;22(34):31–33.Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H. Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin. Exp. Rheumatol. 2004;22(34):31–33.Cobankara V., Fidan G., Turk T., Zencir M., Colakoglu M., Ozen S. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin. Exp. Rheumatol. 2004;22(34):27–30.Cobankara V., Fidan G., Turk T., Zencir M., Colakoglu M., Ozen S. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin. Exp. Rheumatol. 2004;22(34):27–30.Kisacik B., Yildirim B., Tasliyurt T. et al. Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol. Int. 2009;29(11):1307–1309.Kisacik B., Yildirim B., Tasliyurt T. et al. Increased frequency of familial Mediterranean fever in northern Turkey: a population-based study. Rheumatol. Int. 2009;29(11):1307–1309.Lidar M., Yaqubov M., Zaks N., Ben-Horin S., Langevitz P., Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J. Rheumatol. 2006;33(6):1089–1092.Lidar M., Yaqubov M., Zaks N., Ben-Horin S., Langevitz P., Livneh A. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J. Rheumatol. 2006;33(6):1089–1092.Cobankara V., Balkarli A. Ailesel Akdeniz Ateşi. Pam. Med. J. 2011;4(2):86–98.Cobankara V., Balkarli A. Ailesel Akdeniz Ateşi. Pam. Med. J. 2011;4(2):86–98.Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.Ben-Chetrit E., Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.Demirturk L., Ozel A.M., Cekem K., Yazgan Y., Gultepe M. Coexistence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks. Dig. Liver Dis. 2005;37(3):153–158.Demirturk L., Ozel A.M., Cekem K., Yazgan Y., Gultepe M. Coexistence of Helicobacter pylori infection in patients with Familial Mediterranean Fever (FMF) and the effect of Helicobacter pylori on the frequency and severity of FMF attacks. Dig. Liver Dis. 2005;37(3):153–158.Ozel AM, Demirturk L, Aydogdu A, et al. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Int. J. Clin. Pract. 2008;62(5):754–761.Ozel AM, Demirturk L, Aydogdu A, et al. Effect of Helicobacter pylori infection and eradication therapy on interleukin-6 levels in patients with Familial Mediterranean Fever. Int. J. Clin. Pract. 2008;62(5):754–761.Ben-Chetrit E., Ben-Chetrit A. Familial Mediterranean fever and menstruation. BJOG 2001;108(4):403–407.Ben-Chetrit E., Ben-Chetrit A. Familial Mediterranean fever and menstruation. BJOG 2001;108(4):403–407.Toubi E., Gershoni-Baruch R., Kuten A. Cisplatin treatment triggers familial Mediterranean fever attacks. Tumori. 2003;89(1):80–81.Toubi E., Gershoni-Baruch R., Kuten A. Cisplatin treatment triggers familial Mediterranean fever attacks. Tumori. 2003;89(1):80–81.Shohat M, Halpern GJ. Familial Mediterranean fever — a review. Genet. Med. 2011;13(6):487–498.Shohat M, Halpern GJ. Familial Mediterranean fever — a review. Genet. Med. 2011;13(6):487–498.Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351(9103):659–664.Soylu A, Kasap B, Turkmen M, Saylam GS, Kavukcu S. Febrile myalgia syndrome in familial Mediterranean fever. J. Clin. Rheumatol. 2006;12(2):93–96.Soylu A, Kasap B, Turkmen M, Saylam GS, Kavukcu S. Febrile myalgia syndrome in familial Mediterranean fever. J. Clin. Rheumatol. 2006;12(2):93–96.Салугина С.О., Федоров Е.С. Опыт диагностики, лечения и курации пациентов с криопирин-ассоциированными периодическими синдромами в ревматологической практике. Педиатрия. 2018;97(3):103–109.Salugina S.O., Fedorov E.S. Experience of diagnostics, treatment and curation of patients with cryopyrin-associated periodic syndromes in rheumatological practice. Pediatrics. 2018;97(3):103–109. (in Russian).Рамеев В.В., Богданова М.В., Федоров Е.С., Салугина С.О., Симонян А.Х., Моисеев С.В. Козловская Л.В., Мухин Н.А. Современные подходы к лечению колхицинрезистентной периодической болезни. Клиническая фармакология и терапия. 2017;26(3):59–68.Rameev V.V., Bogdanova M.V., Fedorov E.S., Salugina S.O., Simonyan A.Kh., Moiseev S.V. Kozlovskaya L.V., Mukhin N.A. Modern approaches to the treatment of colchicineresistant periodic disease. Clinical pharmacology and therapy. 2017;26(3):59–68. (in Russian)

The authors declare that there are no conflicts of interest present.